1-5 of 5
Laurence J N Cooper, MDPhD
Close
Sort by
Journal Articles

Long Term Follow up after Adoptive Transfer of CD19-Specific CAR + T Cells Genetically Modified Via Non-Viral Sleeping Beauty S ystem Following Hematopoietic Stem Cell Transplantation (HSCT)

Partow Kebriaei, MD, Helen Huls, Simon Olivares, Aaron F Orozco, Shihuang Su, Sourindra N Maiti, Elenanor De Groot, Amy Smith, Yijun Yang, PhD, Gabriela Rondon, MD, Muzaffar H. Qazilbash, MD, Stefan O. Ciurea, Amin M. Alousi, Yago Nieto, MD PhD, David Costa Marin, MD, Uday Popat, MD, Chitra Hosing, MD, Hagop M. Kantarjian, MD, Katayoun Rezvani, MD PhD, Elizabeth J Shpall, MD, Richard E Champlin, MD, Laurence J N Cooper, MDPhD, Harjeet Singh, MSc, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2059.
https://doi.org/10.1182/blood.V130.Suppl_1.2059.2059
Published: 2017
Journal Articles

Shortening the Time to Manufacture CAR + T Cells with Sleeping Beauty System Supports T-Cell Engraftment and Anti-Tumor Effects in Patients with Refractory CD19 + Tumors

Partow Kebriaei, MD, Helen Huls, Susan Lynn Neel, RN, OCN, Simon Olivares, Aaron F Orozco, Shihuang Su, Sourindra N Maiti, Amy Smith, Elenanor De Groot, Hagop M. Kantarjian, MD, Maro Ohanian, DO, Katy Rezvani, MD PhD, Elizabeth J Shpall, MD, Richard E Champlin, MD, Laurence J N Cooper, MDPhD, Harjeet Singh, MSc, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2060.
https://doi.org/10.1182/blood.V130.Suppl_1.2060.2060
Published: 2017
Journal Articles

CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under "Point-of-Care" Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies

Tim Chan, PhD, John Gallagher, Nai-Lin Cheng, PhD, Fernando Carvajal-Borda, DVM, Jacques Plummer, Adeline Govekung, John A Barrett, PhD, Pranay D. Khare, PhD, Laurence J N Cooper, MDPhD, Rutul R Shah
Journal: Blood
Blood (2017) 130 (Supplement 1): 1324.
https://doi.org/10.1182/blood.V130.Suppl_1.1324.1324
Published: 2017
Journal Articles

Autologous T Cells Modified to Co-Express CD33-Specific Chimeric Antigen Receptor and a Kill Switch for Treatment of CD33 + Acute Myeloid Leukemia

Degang Song, PhD, Michael H Swartz, Linhua Tian, Fernando Carvajal-Borda, DVM, Jacques Plummer, Rutul R Shah, William G Wierda, MD PhD, Laurence J N Cooper, MDPhD, Tim Chan, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1376.
https://doi.org/10.1182/blood.V130.Suppl_1.1376.1376
Published: 2017
Journal Articles

Genetically Engineered Regulatory T Cells for Treatment of Graft-Versus-Host-Disease

Eric Tu, PhD, Jennifer Fox, PhD, Christina Ly, BS, Christine Steinhart, PhD, Mike Laporte, MS, James Brennan, PhD, Cheryl Bolinger, PhD, Laurence J N Cooper, MDPhD, Hanspeter Waldner, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3176.
https://doi.org/10.1182/blood.V130.Suppl_1.3176.3176
Published: 2017